Our Publications
Show: AllPeer ReviewedNon Peer Reviewed
16 publications from 2017
R McCafferty, J McHugh, I Regan, A Mannion, G Boran, National Clinical Programme for Pathology Reference Interval Harmonisation Project Group 2nd Draft Survey Report on Reference Intervals for the Full Blood Count in the Republic of Ireland, Royal College of Physicians of Ireland, September, 2017
Maung SW, Burke C, Hayde J, Walshe J, McDermott R, Desmond R, McHugh J, Enright H., A review of therapy-related myelodysplastic syndromes and acute myeloid leukaemia (t-MDS/AML) in Irish patients: a single centre experience., Hematology (Amsterdam, Netherlands), 22, (6), 2017, p341-346
Anthony M McElligott , Eamon P Breen , Ruth Cleary , Sarah Brophy, Fiona McCarthy , Emma Heffernan , Vincent O'Mahony , Nicola Gardiner , Derek G Doherty, Bridgette Byrne , Paul V Browne , Catherine M Flynn, , Characterisation of Naive Immunological Profile of Umbilical Cord Blood: The Role of Mucosal-Associated Invariant T Cells and Functional Defects of T Cells and Natural Killer Cells, Blood, American Society of Hematology, San Diego, CA, USA, 1-4 Dec, 2018, 130, (1), American Society of Hematology, 2017, pp3590-
Appleby, N., Groarke, E., Crowley, M., Wahab, F. A., McCann, A. M., Egan, L., Gough, D., McMahon, G., O'Donghaile, D., O'Keeffe, D., O'Connell, N., Reversal of warfarin anticoagulation using prothrombin complex concentrate at 25 IU kg"1 : results of the RAPID study, Transfusion Medicine, 27, (1), 2017, p66-71
Lim, S.T., Murphy, S.J.X., Smith, D.R., Williams, J., Navarro, S.G., McCabe, J., Moore, D.P., McHugh, J., McCabe, D.J.H., Clinical outcomes and a high prevalence of abnormalities on comprehensive arterial and venous thrombophilia screening in TIA or ischaemic stroke patients with a patent foramen ovale, an interatrial septal aneurysm or both, Journal of the Neurological Sciences, 377, 2017, p227-233
Eyre, T.A., Osborne, W.L., Gallop-Evans, E., Ardeshna, K.M., Kassam, S., Sadullah, S., Sidra, G., Culligan, D., Arumainathan, A., Shankara, P., Bowles, K.M., Eyre, D.W., Peng, Y.Y., Pettengell, R., Bloor, A., Vandenberghe, E., Collins, G.P., Results of a multicentre UK-wide compassionate use programme evaluating the efficacy of idelalisib monotherapy in relapsed, refractory follicular lymphoma, British Journal of Haematology, 2017
Jones, J.A., Robak, T., Brown, J.R., Awan, F.T., Badoux, X., Coutre, S., Loscertales, J., Taylor, K., Vandenberghe, E., Wach, M., Wagner-Johnston, N., Ysebaert, L., Dreiling, L., Dubowy, R., Xing, G., Flinn, I.W., Owen, C., Efficacy and safety of idelalisib in combination with ofatumumab for previously treated chronic lymphocytic leukaemia: an open-label, randomised phase 3 trial, The Lancet Haematology, 4, (3), 2017, pe114-e126
Lavin, M. and Ryan, K. and White, B. and Byrne, M. and O'Connell, N.M. and O'Donnell, J.S., A role for intravenous immunoglobulin in the treatment of Acquired Von Willebrand Syndrome associated with IgM gammopathy, Haemophilia, 2017, pe22-e25
Brophy, T.M. and Ward, S.E. and McGimsey, T.R. and Schneppenheim, S. and Drakeford, C. and O'Sullivan, J.M. and Chion, A. and Budde, U. and O'Donnell, J.S., Plasmin cleaves von willebrand factor at K1491-R1492 in the A1-A2 linker region in a shear- and glycan-dependent manner in vitro, Arteriosclerosis, Thrombosis, and Vascular Biology, 37, (5), 2017, p845-855
Gleeson, E.M. and McDonnell, C.J. and Soule, E.E. and Willis Fox, O. and Rushe, H. and Rehill, A. and Smith, O.P. and O'Donnell, J.S. and Preston, R.J.S., A novel protein Câ"factor VII chimera provides new insights into the structural requirements for cytoprotective protease-activated receptor 1 signaling, Journal of Thrombosis and Haemostasis, 15, (11), 2017, p2198-2207
O'sullivan, J.M. and Preston, R.J.S. and Robson, T. and O'donnell, J.S., Emerging Roles for von Willebrand Factor in Cancer Cell Biology, Seminars in Thrombosis and Hemostasis, 2017
Ghnewa YG, O'Reilly VP, Vandenberghe E, Browne PV, McElligott AM, Doherty DG, Retinoic acid induction of CD1d expression primes chronic lymphocytic leukemia B cells for killing by CD8+ invariant natural killer T cells, Clinical Immunology, 183, 2017, p91 - 98
Elhassadi E, Flavin R, Browne P, Conneally E, Hayden P, Quinn F, Higgins E, Vandenberghe E, Transformed follicular lymphoma (tFL): consolidation therapy may improve survival, Irish Journal of Medical Science, 1863, 2017, p589-595
Byrne CJ, Roberts JA, McWhinney B, Fennell JP, O'Byrne P, Deasy E, Egan S, Desmond R, Enright H, Ryder SA, D'Arcy DM, McHugh J, Variability in trough total and unbound teicoplanin concentrations and achievement of therapeutic drug monitoring targets in adult patients with haematological malignancy, Antimicrobial Agents and Chemotherapy, 61, (6), 2017, pe02466-16
Byrne CJ, Roberts JA, McWhinney B, Ryder SA, Fennell JP, O'Byrne P, Deasy E, Egan S, Desmond R, Enright H, D'Arcy DM, McHugh J, Population pharmacokinetics of teicoplanin and attainment of pharmacokinetic/pharmacodynamic targets in adult patients with haematological malignancy, Clinical Microbiology and Infection, 23, (9), 2017, p674.e7-674.e13
Tobin WO, Kinsella JA, Kavanagh GF, O'Donnell JS, McGrath RT, Tierney S, Egan B, Feeley TM, Coughlan T, Collins DR, O'Neill D, Murphy SJ, Lim SJ, Murphy RP, McCabe DJH, Profile of von Willebrand factor antigen and von Willebrand factor propeptide in an overall TIA and ischaemic stroke population and amongst subtypes., J Neurol Sci, 375, 2017, p404 - 410